Italy has a monitoring system for genetic testing, consisting in a periodic census of clinical and laboratory activities performed in the country. The experience is limited, however, concerning the translation of genomic testing for complex diseases into clinical practice. For the first time the Italian Ministry of Health has introduced a policy strategic plan on genomics and predictive medicine within the 2010-2012 National Prevention Plan. This achievement was supported by the Italian Network for Public Health Genomics (GENISAP) and will likely contribute to the integration of public health genomics into health care in the country. Our experience might be of interest not only in Italy, but in other high-income countries, struggling to keep a healthy economy and healthy citizens.
|Autori interni:||MIGLIORE, LUCIA|
|Autori:||Simone B;Mazzucco W;Gualano MR;Agodi A;Coviello D;Dagna Bricarelli F;Dallapiccola B;Di Maria E;Federici A;Genuardi M;Varesco L;Ricciardi W;Boccia S;GENISAP Network|
|Titolo:||The policy of public health genomics in Italy.|
|Anno del prodotto:||2013|
|Digital Object Identifier (DOI):||10.1016/j.healthpol.2013.01.015|
|Appare nelle tipologie:||1.1 Articolo in rivista|